URGN
UroGen Pharma Ltd
41.60$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.65 | 0.65 | 0.56 | 0.59 | 0.58 | 0.52 | 0.43 | 0.51 | 0.57 | 0.77 | 1.02 | 1.44 | 3.75 | |
| 0.07 | 0.06 | 0.05 | 0.06 | 0.06 | 0.05 | 0.05 | 0.07 | 0.07 | 0.07 | 0.08 | 0.13 | 0.34 | |
| 0.57 | 0.59 | 0.51 | 0.53 | 0.53 | 0.47 | 0.38 | 0.43 | 0.50 | 0.70 | 0.93 | 1.31 | 3.40 | |
| 0.32 | 0.31 | 0.46 | 0.42 | 0.26 | 0.32 | 0.42 | 0.40 | 0.29 | 0.29 | 0.31 | 0.34 | 1.22 | |
| 0.67 | 0.68 | 0.82 | 0.82 | 0.67 | 0.74 | 0.74 | 0.90 | 0.78 | 0.80 | 1.03 | 0.96 | 3.51 | |
| 0.99 | 0.99 | 1.28 | 1.23 | 0.93 | 1.06 | 1.16 | 1.30 | 1.07 | 1.09 | 1.34 | 1.31 | 4.73 | |
| -0.42 | -0.40 | -0.77 | -0.70 | -0.41 | -0.59 | -0.78 | -0.87 | -0.57 | -0.39 | -0.40 | 0.00 | -1.32 | |
| 0.12 | 0.10 | 0.07 | 0.09 | 0.06 | 0.08 | 0.09 | 0.18 | 0.17 | 0.26 | 0.17 | 0.10 | 0.69 | |
| -0.68 | -0.61 | -0.97 | -0.91 | -0.55 | -0.74 | -0.92 | -1.02 | -0.72 | -0.54 | -0.56 | -0.17 | -1.95 | |
| 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.06 | 0.01 | 0.02 | -0.02 | -0.01 | -0.10 | 0.11 | -0.01 | |
| -0.68 | -0.72 | -0.97 | -0.91 | -0.55 | -0.80 | -0.92 | -1.05 | -0.69 | -0.54 | -0.47 | -0.28 | -1.94 | |
| -0.38 | -0.21 | -0.71 | -0.80 | -0.34 | -0.56 | -0.82 | -1.02 | -0.54 | -0.45 | -0.38 | -0.07 | -1.40 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.